Latest Medical Research News and Research
Updated: 39 min 41 sec ago
A new study presents evidence suggestive of restored or increased efficacy from changing the formulation of COVID-19 vaccines to a bivalent one.
Study suggests the behavior of an emergent SARS-CoV-2 variant may be sensitive to the immunologic and demographic context of its location
Researchers characterized the heterogeneity in the speed, magnitude, and timing of 13 SARS-CoV-2 variant transitions/waves.
A recent study claims that the intake of low-calorie sweetener sweeteners does not increase the risk of cancer-related death. However, it may increase the risk of obesity and diabetes.
Researchers showed that some SARS-CoV-2 variants of concern exhibit greater surface and aerosol stability than the ancestral strain.
How did population immunity against SARS-CoV-2 infection and subsequent severe disease change between December 2021 and November 2022?
Researchers explored the alterations in population immunity against SARS-CoV-2 Omicron variant infection and severe disease.
Researchers assessed the immunogenicity and safety of a fourth homologous boost dose of a recombinant SARS-CoV-2 spike protein vaccine called NVX-CoV2373.
Researchers examined whether the mutational process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) itself has changed during the evolution of SARS-CoV-2.
Vaginal birth after a previous cesarean section is associated with an increased risk of pelvic floor surgery compared with planning another cesarean, according to research publishing November 22nd in the open access journal PLOS Medicine.
The binding and functional serologic responses to COVID-19 vaccination in children with history of MIS-C
Researchers evaluated the serological responses elicited by COVID-19 vaccinations in children who developed MIS-C following a previous SARS-CoV-2 infection.
Researchers evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure among rats inhabiting New York City (NYC) during the fall of 2021.
Researchers investigated whether undetected human monkeypox virus transmission occurred before Rotterdam and Amsterdam's first documented monkeypox cases.
In a recent article published in the journal Cell, researchers found fungal deoxyribonucleic acid (DNA) and cells at low abundances across many human cancers, with cancer type-dependent variations in fungus community composition and fungal-bacteriome interactions.
In a recent study published in the Canadian Medical Association Journal, researchers observed the incidence of myocarditis following messenger ribonucleic acid (mRNA)-based vaccination against coronavirus disease 2019 (COVID-19). Additionally, they compared their estimates with expected rates based on the historical rates assessed before the COVID-19 vaccination rollout in British Columbia (BC), Canada.
In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in combating a lethal Vaccinia virus (VACV) challenge in mice models.
An international team of scientists investigating transmission of a deadly drug-resistant bacteria that rivals MRSA, has found that whilst the bugs are found in livestock, pets and the wider environment, they are rarely transmitted to humans through this route.
The idea that what we eat directly affects our health is ancient; Hippocrates recognized this as far back as 400 B.C. But, identifying healthier foods in the supermarket aisle and on restaurant menus is increasingly challenging.
Ultrapotent IgM antibodies isolated from a pregnant woman with Zika virus show promise as an immunotherapy
Zika virus (ZIKV) infection is a potentially teratogenic illness, causing up to one in seven infants born to infected mothers to suffer neurodevelopmental deficits. A new study published in the journal Cell shows that some mothers escape injury to their babies because they develop a highly potent neutralizing antibody.
Plant-based monoclonal antibody increases potency of antibody cocktail against SARS-CoV-2 Omicron variant
A novel mAb against the SARS-CoV-2 RBD through a hybridoma technique, followed by chimerization and expression in plants.
In a step likely to advance personalized cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.
Researchers investigate alterations in the semen microbiome before and after the vasectomy procedure.